Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Websitemvmlifescience.com
Phone44-(0)20-7557-7500
Employees
Founded1997
DescriptionLife Sciences Investment

Funds

Medtech Fund, 1/2013 $225M

Offices

HQ
6 Henrietta Street
London, WC2E 8PU, GBR
Boston, USA
Old City Hall
45 School Street
Boston, MA, 02108
USA

People

Partner
Partner
Partner
Partner
Finance Partner
Team Member

Tags

MVM Life Science Partners

MVM was founded in 1997 and manages three funds totalling more than US$500 million. MVM has invested in biopharmaceuticals, diagnostics, drug delivery, gene therapy, healthcare services, medical devices, OTC medicines, research tools and vaccines.

Recent Milestones

Investments

Company Date Round Size Participants
Wilson Therapeutics 4/2014Series B$40M2
Cheetah Medical 2/2014Series C$28.8M5
Horizon Discovery 6/2013Series C£6.9M11
eZono 1/2013Venture Round$10M1
Tarsa Therapeutics 3/2012Series B$28M4
Horizon Discovery 1/2012Series C$18.6M3
Beacon Endoscopic 8/2011Venture Round$8M1
AccuVein 7/2011Series B$22.5M2
Vantia Therapeutics 7/2011Series B$6.5M3
Vascular Pathways 11/2010Series B$14M4
Cara Therapeutics 7/2010Series D$15M8
Cheetah Medical 4/2010Series B$20M3
Tarsa Therapeutics 1/2010Series A$24M3
BioVex 11/2009Series F$30M5
Cara Therapeutics 11/2006Series C$19M3

Videos

Sources

  1. MVM Life Science Partners to Raise $225M Medtech Fund This Year (pevc.dowjones.com) [edit]
  2. Wilson Therapeutics Secures $40 Million Private Financing To Advance Late Stage Development Program For Wilson's Disease (prnewswire.com) [edit]
  3. SEC D/A (sec.gov) [edit]
  4. Horizon Discovery Announces £6.9 Million ($10.5 Million) Series C Continuation Fundraising (horizondiscovery.com) [edit]
  5. eZono Raises $10M in Funding (finsmes.com) [edit]
  6. Tarsa Therapeutics Completes $28 Million Series B Financing to Advance OSTORA™ Oral Calcitonin (prnewswire.com) [edit]
  7. Horizon Discovery, Ltd.: Series C $18.6M (onbiovc.com) [edit]
  8. Beacon Endoscopic draws $8M in two fundings (masshightech.com) [edit]
  9. AccuVein Secures $22.5M in Series B Financing (finsmes.com) [edit]
  10. Vantia Therapeutics Raises £4 Million to Fund Clinical Development of its Lead Compounds (vantiatherapeutics.com) [edit]
  11. Vascular Pathways Closes $14M Series B Financing (finsmes.com) [edit]
  12. Cara rounds up $15M for post-op pain drug Read more: Cara rounds up $15M for post-op pain drug (fiercebiotech.com) [edit]
  13. Cheetah Medical, Inc.: Series B $20M (onbiovc.com) [edit]
  14. Tarsa Therapeutics, Inc.: Series A $24M (onbiovc.com) [edit]
  15. Xconomy Boston (xconomy.com) [edit]
  16. Cara Therapeutics Secures $19 Million in Series C Financing. (thefreelibrary.com) [edit]
Edit This Page
Last Edited 4/16/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy